This is particularly notable given emerging evidence that tumor-associated macrophages (TAMs) can directly phagocytose viable cancer cells via modulation of the CD47/CXCR4/CXCL12 axis, a process referred to as “immune surrender” [28]. Here, CXCR4 is linked to neoplasm.